Theophylline: Its rise, demise, and resurrection

Clinical Pediatric Emergency Medicine

Volumn 1, Issue 3, 2000, Pages 213-221

  Shannon, Michael ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 10644258874     PISSN: 15228401     EISSN: None     Source Type: Journal    
DOI: 10.1053/cpem.2000.6073     Document Type: Article

References (60)

1. McFadden ER: Methylxanthines in the treatment of asthma: The rise, the fall, and the possible rise again. Ann Intern Med 115:323-324, 1991.
2. Weinberger M, Hendeles L: Theophylline in asthma. N Engl J Med 334:1380-1388, 1996.
3. Weinberger M, Hendeles L: Slow-release theophylline - Rationale and basis for product selection. N Engl J Med 308:760-764, 1988.
4. Butts JD, Secrest B, Berger R: Nonlinear theophylline pharmacokinetics - A preventable cause of iatrogenic theophylline toxic reactions. Arch Intern Med 151: 2073-2077, 1991.
5. Martin R: Nocturnal asthma and the use of theophylline. Clin Exp Allergy 28 3:64-70, 1998 (suppl).
6. Shannon M: Drug-drug interactions and the cytochrome P450 system: An update. Pediatr Emerg Care 13:350-353, 1997.
7. American Academy of Pediatrics, Committee on Drugs: Precautions concerning the use of theophylline. Pediatrics 89:781-782, 1992.
8. Hendeles L, Jenkins J, Temple R: Revised FDA labeling guidelines for theophylline oral dosage forms. Pharmacotherapy 15:409-427, 1995.
9. Murciano D, Auclair M-H, Pariente R, et al: A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med 320:1521-1525, 1989.
10. Wrenn K, Slovis GM, Murphy F, et al: Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med 115:241-247, 1991.
11. Evans D, Taylor D, Zetterstrom O, et al: A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 337:1412-1418, 1997.
12. Epstein PE: Hemlock or healer? The mercurial reputation of theophylline. Ann Intern Med 119:1216-1217, 1993.
13. Tohda Y, Nakahara H, Kubo H, et al: Theophylline suppresses the release of interleukin-4 by peripheral blood mononuclear cells. Int Arch Allergy Immunol 115: 42-46, 1998.
14. Page G: Recent advances in our understanding of the use of theophylline in the treatment of asthma. J Clin Pharmacol 39:237-240, 1999.
15. Myers T, Milsap R, Krauss A, et al: Low-dose theophylline therapy in idiopathic apnea of prematurity. J Pediatr 96:99-103, 1980.
16. Serafin WE: Drugs used in the treatment of asthma, in Hardman J, Limbird L, Molinoff P, et al (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, NY, McGraw-Hill, 1996, pp 659-682.
17. Davi M, Sankaran K, Simons K, et al: Physiologic changes induced by theophylline in the treatment of apnea in preterm infants. J Pediatr 92:91-95, 1978.
18. Schmidt B: Methylxanthine therapy in premature infants: Sound practice, disaster, or fruitless byway. J Pediatr 135:526-528, 1999.
19. Shannon M: Life-threatening events after theophylline overdose - A 10-year prospective analysis. Arch Intern Med 159:989-994, 1999.
20. Shannon M, Lovejoy F: Effect of acute versus chronic intoxication on clinical features of theophylline poisoning in children. J Pediatr 121:125-130, 1992.
21. Shannon M: Predictors of major toxicity after theophylline overdose. Ann Intern Med 119:1161-1167, 1993.
22. Baker MD: Theophylline toxicity in children. J Pediatr 109:538-542, 1986.
23. Skinner MH: Adverse reactions and interactions with theophylline. Drug Safety 5:275-285, 1990.
24. Curry SC, Vance MV, Requa R, et al: Cardiovascular effects of toxic concentrations of theophylline in the dog. Ann Emerg Med 14:547-553, 1985.
25. Kearney TE, Manoguerra AS, Curtis GP, et al: Theophylline toxicity and the beta-adrenergic system. Ann Intern Med 102:766-769, 1985.
26. Higbee MD, Kumar M, Galant SP: Stimulation of endogenous catecholamine release by theophylline: A proposed additional mechanism of action for theophylline effects. J Allergy Clin Immunol 70:377-382, 1982.
27. Vestal RE, Eiriksson CE, Musser B, et al: Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man. Circulation 67:162-171, 1983.
28. Nakada T, Keww IL, Lerner AM, et al: Theophylline-induced seizures: Clinical and pathophysiologic aspects. West J Med 138:371-374, 1983.
29. Bahls F, Ma KK, Bird TD: Theophyline-associated seizures with "therapeutic" or low toxic serum concentrations: Risk factors for serious outcome in adults. Neurology 41:1309-1312, 1991.
30. Richards W, Church JA, Brent DK: Theophylline-associated seizures in children. Ann Allergy 54:276-279, 1985.
31. Woody RG, Laney M: A second case of infantile intracranial hemorrhage and severe neurological sequelae following theophylline overdose. Dev Med Child Neurol 28:120-121, 1986.
32. Eldridge P, Paydarfar D, Scott S, et al: Role of endogenous adenosine in recurrent generalized seizures. Exp Neurol 103:179-185, 1989.
33. Shannon M, Maher T: Anticonvulsant effects of intracerebroventricular Adenocard in theophylline-induced seizures. Ann Emerg Med 26:65-68, 1995.
34. Dragunow M: Adenosine receptor antagonism accounts for the seizure-prolonging effects of aminophylline. Pharmacol Biochem Behav 36:751-755, 1990.
35. Cavelheiro EA, Filho LSC, Bortolotto ZA, et al: Anticonvulsant role of adenosine. Pol J Pharmacol Pharm 39:537-544, 1987.
36. Pinard E, Riche D, Puiroud S, et al: Theophylline reduces cerebral hyperaemia and enhances brain damage induced by seizures. Brain Res 511:303-309, 1990.
37. Sessler CN: Poor tolerance of oral activated charcoal with theophylline overdose. Am J Emerg Med 5:492-495, 1987.
38. Shannon M, Lovejoy F: Hypokalemia after theophylline intoxication - The effects of acute vs. chronic poisoning. Arch Intern Med 149:2725-2729, 1989.
39. Clausen T: Adrenergic control of Na-K-homeostasis. Acta Med Scand 672:111-115, 1983 (suppl).
40. Clausen T, Flatman JA: Beta-2 adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscle. Br J Pharmacol 68:749-755, 1980.
41. Shannon M: Hypokalemia, hyperglycemia and plasma catecholamine activity after severe theophylline intoxication. J Toxicol Clin Toxicol 32:41-47, 1994.
42. McPherson ML, Prince SR, Atamer ER, et al: Theophylline-induced hypercalcemia. Ann Intern Med 105: 52-54, 1986.
43. Amitai Y, Lovejoy FH: Hypokalemia in acute theophylline poisoning. Am J Emerg Med 6:214-218, 1988.
44. Sawyer WT, Caravati EM, Ellison MJ, et al: Hypokalemia, hyperglycemia, and acidosis after intentional theophylline overdose. Am J Emerg Med 3:408-411, 1985.
45. Olson KR, Benowitz NL, Woo OF, et al: Theophylline overdose: Acute single ingestion versus chronic repeated overmedication. Am J Emerg Med 3:386-394, 1985.
46. Bertino JS, Walker JW: Reassessment of theophylline toxicity-serum concentrations, clinical course, and treatment. Arch Intern Med 147:757-760, 1987.
47. Shannon M, Lovejoy F: The influence of age vs. peak serum concentration of life-threatening events after chronic theophylline intoxication. Arch Intern Med 150: 2045-2048, 1990.
48. D'Angio R, Sabatelli F: Management considerations in treating metabolic abnormalities associated with theophylline overdose. Arch Intern Med 147:1837-1838, 1987.
49. Kulig KW, Bar-Or D, Rumack BH: Intravenous theophylline poisoning and multiple dose charcoal in an animal model. Ann Emerg Med 16:842-846, 1987.
50. Heath A, Knudsen R: Role of extracorporeal drug removal in acute theophylline poisoning - A review. Med Toxicol 2:294-308, 1987.
51. Shannon M, Amitai Y, Lovejoy FH: Multiple-dose activated charcoal for theophylline poisoning in young infants. Pediatrics 80:368-370, 1987.
52. Roberts JR, Carney S, Boyle SM, et al: Ondansetron quells drug-resistant emesis in theophylline poisoning. Am J Emerg Med 11:609-611, 1993.
53. Amitai Y, Yeung AC, Moye J, et al: Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity. Ann Intern Med 105:386-387, 1986.
54. Shannon M: Theophylline and caffeine, in Haddad L, Shannon M, Winchester J (eds): Clinical Management of Poisoning and Drug Overdose (ed 3). Philadelphia, PA, Saunders, 1998, pp 1093-1106.
55. Russo ME: Management of theophylline intoxication with charcoal-column hemoperfusion. N Engl J Med 300:24-26, 1979.
56. Lynn KL, Buttomore AL, Begg EJ, et al: Treatment of theophylline poisoning with haemoperfusion. N Z Med J 101:4-5, 1988.
57. Sahney S, Abarzua J, Sessums L: Hemoperfusion in theophylline neurotoxicity. Pediatrics 71:615-619, 1983.
58. Shannon M: Comparative efficacy of hemodialysis and hemoperfusion in severe theophylline intoxication. Acad Emerg Med 4:674-678, 1997.
59. Osborn HH, Henry G, Wax P, et al: Theophylline toxicity in a premature neonate-elimination kinetics of exchange transfusion. J Toxicol Clin Toxicol 31:639-644, 1993.
60. Shannon M, Wernovsky G, Morris C: Exchange transfusion in the treatment of severe theophylline poisoning. Pediatrics 89:145-147, 1992.